This topic contains a solution. Click here to go to the answer

Author Question: What destroys the red cells in paroxysmal nocturnal hemoglobinuria? a. Macrophages in the bone ... (Read 90 times)

dbose

  • Hero Member
  • *****
  • Posts: 597
What destroys the red cells in paroxysmal nocturnal hemoglobinuria?
 
  a. Macrophages in the bone marrow
  b. Antibodies against red cell membrane antigens
  c. Increased susceptibility to complement
  d. Macrophages in the spleen

Question 2

Which of the following is a typical finding in paroxysmal nocturnal hemoglobinuria?
 
  a. Hemosiderin in urine sediment
  b. Normal levels of decay accelerating factor (CD55)
  c. Hemolysis when blood is alkaline
  d. Elevated white cells and platelets



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

JaynaD87

  • Sr. Member
  • ****
  • Posts: 368
Answer to Question 1

ANS: C
Red cells in paroxysmal nocturnal hemoglobinuria are abnormally sensitive to complement, which is activated on their surface and results in premature destruction of the red cells.

Answer to Question 2

ANS: A
Hemosiderin is present and a useful diagnostic tool in paroxysmal nocturnal hemoglobinuria. Levels of CD55 are decreased in paroxysmal nocturnal hemoglobinuria. Hemolysis occurs when blood is acidic, and platelets and white cells are usually decreased so that the patient is pancytopenic.




dbose

  • Member
  • Posts: 597
Reply 2 on: Jun 25, 2018
Excellent


lkanara2

  • Member
  • Posts: 329
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

The FDA recognizes 118 routes of administration.

Did you know?

Asthma occurs in one in 11 children and in one in 12 adults. African Americans and Latinos have a higher risk for developing asthma than other groups.

Did you know?

The word drug comes from the Dutch word droog (meaning "dry"). For centuries, most drugs came from dried plants, hence the name.

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library